awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38150859-416F91A2-2688-420E-91F0-C52A38F3209A
Q38150859-416F91A2-2688-420E-91F0-C52A38F3209A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38150859-416F91A2-2688-420E-91F0-C52A38F3209A
Overview of subsequent entry biologics for the management of inflammatory bowel disease and Canadian Association of Gastroenterology position statement on subsequent entry biologics.
P2860
Q38150859-416F91A2-2688-420E-91F0-C52A38F3209A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38150859-416F91A2-2688-420E-91F0-C52A38F3209A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
eac20abd80c5e9b5ede291e7f327a1e81ba88346
P2860
Shifting paradigms: biopharmaceuticals versus low molecular weight drugs.